Possibly of interest:
Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases.
Fernández-Moriano C, González-Burgos E, Gómez-Serranillos MP.
Oxid Med Cell Longev. 2015;2015:408927.
ncbi.nlm.nih.gov/pubmed/260...
"Table 1 reports compounds that have been demonstrated to be promising
agents in the protection of mitochondrial dysfunction in different
Parkinson's disease models."
Table 1. Parkinson's disease and mitochondria-targeted protective compounds.